Clostridium difficile infection and inflammatory bowel disease

Sheela S. Reddy, Lawrence J. Brandt

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

The prevalence of Clostridium difficile infection (CDI) in inflammatory bowel disease (IBD) has become a focus of increased attention, as the C. difficile epidemic continues to grow. Although first documented more than 20 years ago, only in recent years has the relationship between these 2 entities been better clarified, and recent epidemiologic studies have shown that IBD patients are at increased susceptibility for CDI compared with the general population. Despite this increased attention, much still remains unknown, and the overlapping clinical presentations of CDI and IBD pose barriers to diagnosis and standardized treatment. Moreover, given the relationship between mortality and severity of CDI in IBD patients, early recognition of those who are at increased risk for infection is of paramount importance to improve patient outcome.

Original languageEnglish (US)
Pages (from-to)666-671
Number of pages6
JournalJournal of Clinical Gastroenterology
Volume47
Issue number8
DOIs
StatePublished - Sep 2013

Fingerprint

Clostridium Infections
Clostridium difficile
Inflammatory Bowel Diseases
Epidemiologic Studies
Mortality
Infection
Population

Keywords

  • Clostridium difficile infection
  • Colitis
  • Inflammatory bowel disease

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Clostridium difficile infection and inflammatory bowel disease. / Reddy, Sheela S.; Brandt, Lawrence J.

In: Journal of Clinical Gastroenterology, Vol. 47, No. 8, 09.2013, p. 666-671.

Research output: Contribution to journalArticle

@article{428af79a72514dd2bdafa869e67a8ab7,
title = "Clostridium difficile infection and inflammatory bowel disease",
abstract = "The prevalence of Clostridium difficile infection (CDI) in inflammatory bowel disease (IBD) has become a focus of increased attention, as the C. difficile epidemic continues to grow. Although first documented more than 20 years ago, only in recent years has the relationship between these 2 entities been better clarified, and recent epidemiologic studies have shown that IBD patients are at increased susceptibility for CDI compared with the general population. Despite this increased attention, much still remains unknown, and the overlapping clinical presentations of CDI and IBD pose barriers to diagnosis and standardized treatment. Moreover, given the relationship between mortality and severity of CDI in IBD patients, early recognition of those who are at increased risk for infection is of paramount importance to improve patient outcome.",
keywords = "Clostridium difficile infection, Colitis, Inflammatory bowel disease",
author = "Reddy, {Sheela S.} and Brandt, {Lawrence J.}",
year = "2013",
month = "9",
doi = "10.1097/MCG.0b013e31828b288a",
language = "English (US)",
volume = "47",
pages = "666--671",
journal = "Journal of Clinical Gastroenterology",
issn = "0192-0790",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Clostridium difficile infection and inflammatory bowel disease

AU - Reddy, Sheela S.

AU - Brandt, Lawrence J.

PY - 2013/9

Y1 - 2013/9

N2 - The prevalence of Clostridium difficile infection (CDI) in inflammatory bowel disease (IBD) has become a focus of increased attention, as the C. difficile epidemic continues to grow. Although first documented more than 20 years ago, only in recent years has the relationship between these 2 entities been better clarified, and recent epidemiologic studies have shown that IBD patients are at increased susceptibility for CDI compared with the general population. Despite this increased attention, much still remains unknown, and the overlapping clinical presentations of CDI and IBD pose barriers to diagnosis and standardized treatment. Moreover, given the relationship between mortality and severity of CDI in IBD patients, early recognition of those who are at increased risk for infection is of paramount importance to improve patient outcome.

AB - The prevalence of Clostridium difficile infection (CDI) in inflammatory bowel disease (IBD) has become a focus of increased attention, as the C. difficile epidemic continues to grow. Although first documented more than 20 years ago, only in recent years has the relationship between these 2 entities been better clarified, and recent epidemiologic studies have shown that IBD patients are at increased susceptibility for CDI compared with the general population. Despite this increased attention, much still remains unknown, and the overlapping clinical presentations of CDI and IBD pose barriers to diagnosis and standardized treatment. Moreover, given the relationship between mortality and severity of CDI in IBD patients, early recognition of those who are at increased risk for infection is of paramount importance to improve patient outcome.

KW - Clostridium difficile infection

KW - Colitis

KW - Inflammatory bowel disease

UR - http://www.scopus.com/inward/record.url?scp=84883251271&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883251271&partnerID=8YFLogxK

U2 - 10.1097/MCG.0b013e31828b288a

DO - 10.1097/MCG.0b013e31828b288a

M3 - Article

VL - 47

SP - 666

EP - 671

JO - Journal of Clinical Gastroenterology

JF - Journal of Clinical Gastroenterology

SN - 0192-0790

IS - 8

ER -